Health

South Africa can afford antiretroviral treatment

Based on existing resources, South Africa can '€œeasily afford'€ to provide anti-retroviral therapy to between 60 000 and 70 000 people in the next five years. This was the conclusion from a study by Dr Chris Kenyon of the Health Systems Trust and Dr Andrew Boulle, a registrar in the School of Public Health at the University of Cape Town, presented at the 14th World Conference on AIDS in Barcelona yesterday (Tuesday).

Read More » South Africa can afford antiretroviral treatment

Real impact of AIDS left off the agenda

The impact the AIDS epidemic is having now, will be worse in the years ahead and the way to change it'€™s course is to try and see where the epidemic is going rather than relying on crystal ball modeling. Speaking at the 14th World AIDS Conference, Professor Alan Whiteside, Director of Natal University'€™s HIV/AIDS Research Division said it was clear from the agenda that the scientists knew a great deal, but little was known on the social science (impact) of the epidemic.

Read More » Real impact of AIDS left off the agenda

No reason not to get anti-retroviral drugs to the poor

There is no longer any reason to believe that it should not be possible to get anti-retrovirals to poorer nations, the World Health Organisation said today (Monday). Addressing the first session of the 14th International Conference on HIV/AIDS, Dr Bernhard Schwartlander, director of HIV/AIDS at the WHO said Brazil had shown the way in that it actually cost less money to give people anti-retrovirals that to just let them die.

Read More » No reason not to get anti-retroviral drugs to the poor

Generic competition drives down drug prices

Competition between drug companies and generic producers has been far more effective in ensuring cheaper anti-AIDS drugs than negotiations with drug companies. This is despite a massive humanitarian initiative launched two years at the 13th world AIDS conference by the Joint UN Programme on HIV/AIDS (UNAIDS) and five of the world'€™s biggest pharmaceutical companies aimed at ensuring that developing countries had access to cheaper drugs. KERRY CULLINAN reports.

Read More » Generic competition drives down drug prices

SA shares treatment lessons at World AIDS forum
Living with AIDS programme 83

It's been two years since the world met in Durban to exchange knowledge and experiences about the response to the HIV/AIDS pandemic. This Sunday, the 14th International AIDS conference opens in Barcelona, Spain. In this audio report two researchers working in Khayelitsha, Cape Town give a preview of papers they will present at Barcelona detailing the provision of antiretroviral therapy in resource-poor settings through the public health system.

Read More » SA shares treatment lessons at World AIDS forum
Living with AIDS programme 83

Newsletter Subscription

Be in the know with our free weekly newsletter. We deliver a round-up of our top stories and insightful reads from across the web.

  • This field is for validation purposes and should be left unchanged.
Enable Notifications OK No thanks